Charles J. Homcy - 23 Oct 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role
Director
Signature
/s/ Courtney Phillips, as attorney-in-fact
Issuer symbol
MAZE
Transactions as of
23 Oct 2025
Net transactions value
$0
Form type
4
Filing time
27 Oct 2025, 16:46:23 UTC
Previous filing
24 Sep 2025
Next filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HOMCY CHARLES J Director C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO /s/ Courtney Phillips, as attorney-in-fact 27 Oct 2025 0001192591

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAZE Common Stock Gift $0 -28,423 -49% $0.000000 29,624 23 Oct 2025 Direct F1
holding MAZE Common Stock 7,422 23 Oct 2025 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction represents a gift, for no consideration, which is exempt pursuant to Rule 16b-5.
F2 These securities are directly held by the Charles J. Homcy Revocable Trust UA 11/4/1998, of which the reporting person is the trustee.